Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Granulation
Solubilizers
Lubricants & Glidants
Coating Systems & Additives
Thickeners and Stabilizers
Film Formers & Plasticizers
Controlled & Modified Release
Direct Compression
Taste Masking
Parenteral
Surfactant & Foaming Agents
Rheology Modifiers
Emulsifying Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Hydrocortisone Valerate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydrocortisone Valerate, including repackagers and relabelers. The FDA regulates Hydrocortisone Valerate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydrocortisone Valerate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hydrocortisone Valerate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hydrocortisone Valerate supplier is an individual or a company that provides Hydrocortisone Valerate active pharmaceutical ingredient (API) or Hydrocortisone Valerate finished formulations upon request. The Hydrocortisone Valerate suppliers may include Hydrocortisone Valerate API manufacturers, exporters, distributors and traders.
click here to find a list of Hydrocortisone Valerate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hydrocortisone Valerate DMF (Drug Master File) is a document detailing the whole manufacturing process of Hydrocortisone Valerate active pharmaceutical ingredient (API) in detail. Different forms of Hydrocortisone Valerate DMFs exist exist since differing nations have different regulations, such as Hydrocortisone Valerate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hydrocortisone Valerate DMF submitted to regulatory agencies in the US is known as a USDMF. Hydrocortisone Valerate USDMF includes data on Hydrocortisone Valerate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hydrocortisone Valerate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hydrocortisone Valerate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hydrocortisone Valerate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hydrocortisone Valerate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hydrocortisone Valerate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hydrocortisone Valerate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hydrocortisone Valerate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hydrocortisone Valerate suppliers with NDC on PharmaCompass.
Hydrocortisone Valerate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hydrocortisone Valerate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydrocortisone Valerate GMP manufacturer or Hydrocortisone Valerate GMP API supplier for your needs.
A Hydrocortisone Valerate CoA (Certificate of Analysis) is a formal document that attests to Hydrocortisone Valerate's compliance with Hydrocortisone Valerate specifications and serves as a tool for batch-level quality control.
Hydrocortisone Valerate CoA mostly includes findings from lab analyses of a specific batch. For each Hydrocortisone Valerate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hydrocortisone Valerate may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydrocortisone Valerate EP), Hydrocortisone Valerate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydrocortisone Valerate USP).
LOOKING FOR A SUPPLIER?
